Condition category
Surgery
Date applied
09/11/2012
Date assigned
18/12/2012
Last edited
13/11/2015
Prospective/Retrospective
Prospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
At some time in their life, 60% to 80% of people will have low back problems and surgery for its treatment is the greatest cost to the NHS. Lumbar discectomy surgery is a common procedure for patients with pain in their legs. However, 30-70% of patients continuing to have problems even after the surgery. Recovery after surgery is, therefore, an important area to research. Currently, treatment following lumbar discectomy comprises a patient leaflet or physiotherapy or both. Practice varies across hospitals and it is unknown whether providing a patient leaflet and physiotherapy benefits patients' recovery compared with use of a patient leaflet alone. This is why we are conducting the study. This study is conducted to help us improve the design and prospects to do a future larger study.

Who can participate?
Men and women aged more than 18 years who have recently undergone the first lumbar discectomy surgery can participate.

What does the study involve?
All participants will be asked to attend two assessment clinics at 4 and 16 weeks after surgery and half the participants, at each hospital, will be asked to attend a third assessment clinic at 30 weeks after surgery. Assessments comprise of a short questionnaire and two simple physical tests that assess how well patients can move their back and legs. Patients will be randomly allocated one of the following groups: Patient leaflet and individual outpatient physiotherapy, or, patient leaflet alone; and 30-week follow-up, or, not. Participants allocated to receive individual outpatient physiotherapy and the patient leaflet will receive up to 8 treatment sessions with a physiotherapist, starting as soon as possible after the 4-week assessment clinic. At their final assessment visit, participants will be invited to attend a meeting with other participants who received the same treatment, to discuss their experience.

What are the possible benefits and risks of participating?
We cannot promise that taking part in the study will help the participants, but the information obtained could help them and patients like them in the future. All participants will receive a copy of a Patient Leaflet that has been designed specifically for patients following lumbar discectomy surgery. The leaflet contains information about the patient's back, surgery and recovery after surgery. There are no known risks of taking part in the study.

Where is the study run from?
Queen Elizabeth Hospital Birmingham (UK) and Salford Royal NHS Foundation Trust (UK).

When is the study starting and how long is it expected to run for?
Recruitment for the study started in January 2013. Participants will be enrolled on the study for 7 months.

Who is funding the study?
Queen Elizabeth Hospital Birmingham Charity, UK.

Who is the main contact?
Dr Alison Rushton
a.b.rushton@bham.ac.uk

Trial website

Contact information

Type

Scientific

Primary contact

Dr Alison Rushton

ORCID ID

Contact details

University of Birmingham
School of Health & Population Sciences
College of Medical and Dental Sciences
52 Pritchatts Road
Edgbaston
Birmingham
B15 2TT
United Kingdom
+44 (0)121 415 8597
a.b.rushton@bham.ac.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

1

Study information

Scientific title

QUeen Elizabeth Physiotherapy post lumbar discectomy STudy: a feasibility and pilot phase II trial to inform the development of a future phase III randomised controlled trial (QUEST)

Acronym

QUEST

Study hypothesis

One to one physiotherapy plus the Patient Leaflet will be more beneficial than the Patient Leaflet (phase II trial)

Ethics approval

West Midlands - Solihull Research Ethics Committee, 25/09/2012, ref: 12/WM/0224

Study design

Pilot/feasibility study of a randomised controlled trial with two arms

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Treatment

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Rehabilitation following lumbar spinal surgery

Intervention

1. Up to 8 sessions of individualised 1-1 physiotherapy over an 8-week period; treatment in-line with pre-defined framework for decision-making; starting approximately 4 weeks post surgery AND specifically designed patient leaflet
2. Specifically designed patient leaflet

Intervention type

Behavioural

Phase

Drug names

Primary outcome measures

Roland Morris Disability Questionnaire (0 to 24)

Secondary outcome measures

1. Global Perceived Effect scale (0 to 7)
2. VAS back pain (0 to 10cm) & VAS leg pain (0 to 10cm)
3. Straight Leg Raise (cm)
4. Time to return to work / normal function / full duty (as relevant) from date of operation
5. EQ-5D 5L
6. Tampa Scale for Kinesiophobia (fear of movement)
7. Fear avoidance and beliefs questionnaire
8. Range of lumbar movement
9. Use of medication
10. Re-operation
11. Level of compliance with exercises

Overall trial start date

26/10/2012

Overall trial end date

26/05/2014

Reason abandoned

Eligibility

Participant inclusion criteria

1. Male and female patients aged >18 years
2. Post primary, single level, lumbar discectomy (including microdiscectomy)
3. Ability to communicate in English

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

70

Participant exclusion criteria

1. Previous surgery at the same spinal level
2. Co-morbidities that might impact on ability to participate in study interventions e.g. neurological disorders, cognitive dysfunction, uncontrolled cardiovascular disease, osteoporotic fracture, spondylolythesis, MS, tumour
3. Complications from surgery e.g. excessive bleeding, severe intra-operative root damage, level error, or severe wound infection that would prevent participation in either intervention
4. Participation in a concurrent trial

Recruitment start date

13/01/2013

Recruitment end date

26/05/2014

Locations

Countries of recruitment

United Kingdom

Trial participating centre

University of Birmingham
Birmingham
B15 2TT
United Kingdom

Sponsor information

Organisation

University of Birmingham (UK)

Sponsor details

Research Governance Team
Aston Webb Building
Edgbaston
Birmingham
B15 2TT
United Kingdom
+44 (0)121 414 4418
researchgovernance@contacts.bham.ac.uk

Sponsor type

University/education

Website

http://www.birmingham.ac.uk/researchsupportgroup

Funders

Funder type

Charity

Funder name

Queen Elizabeth Hospital Birmingham Charity (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2015 results in: http://www.ncbi.nlm.nih.gov/pubmed/26562660

Publication citations

Additional files

Editorial Notes